Prohibition on copay accumulator adjustments.
SB 435 prohibits insurers from using copay accumulator adjustments, requiring manufacturer copay assistance to count toward patient deductibles and out-of-pocket maximums.
SB 435 prohibits insurers from using copay accumulator adjustments, requiring manufacturer copay assistance to count toward patient deductibles and out-of-pocket maximums.
SB 435 would prohibit health insurers from using "copay accumulator adjustments" — practices where manufacturer copay assistance programs don't count toward a patient's deductible or out-of-pocket maximum. The bill aims to prevent insurers from essentially negating the financial help that drug manufacturers provide to patients, requiring all copay assistance to count toward cost-sharing requirements.
Copay accumulators create a hidden cost burden for patients with expensive medications, particularly those with chronic or serious conditions. Without this prohibition, patients receiving manufacturer assistance may still face unexpected out-of-pocket costs after reaching their deductible, effectively undermining the intended financial relief and potentially limiting medication access for vulnerable populations.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.